Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/6F9A7C79.svg?ark=w1%2F20260526%2F6F9A7C79)](https://nobleid.org/work/w1/20260526/6F9A7C79)

ARK Inflections

Authors & Claims

Paper Authors